Friday, 17 May 2013

Roche has filed obinutuzumab on both sides of the Atlantic to treat chronic lymphocytic leukaemia.


Roche files next-generation Rituxan in USA, EU
Roche has filed obinutuzumab on both sides of the Atlantic to treat chronic lymphocytic leukaemia.May 16, 2013
read all at

http://newdrugapprovals.wordpress.com/2013/05/17/roche-files-next-generation-rituxan-in-usa-eu/
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)